Osanetant(CAS: 160492-56-8)

Osanetant (CAS: 160492-56-8) should comply with GHS classification for hazardous chemicals, REACH regulations for substances placed on the European market, and FDA and EPA requirements for pharmaceutical and chemical products, respectively. Companies must ensure that they follow the guidelines for safe handling, storage, and disposal of the compound.

There are no direct alternatives to Osanetant (CAS: 160492-56-8) in its current form. However, related compounds with similar pharmacological activities, such as isomers and analogs, may be explored as potential alternatives in certain synthetic routes. Researchers often use substitute reagents and solvents to achieve similar results.

Osanetant (CAS: 160492-56-8) is primarily in the research phase, focusing on its potential as an antagonist for adenosine A3 receptors. Market trends indicate increasing interest in its therapeutic applications, particularly in respiratory and inflammatory diseases. However, due to its early stages, there is currently no significant commercial market for the compound.

Waste containing Osanetant (CAS: 160492-56-8) should be collected in appropriate containers, sealed, and stored in a secure location to prevent exposure. Proper incineration or professional waste disposal services should be utilized to ensure the safe disposal of the waste. Environmental protection precautions, such as minimizing the release of hazardous compounds into the environment, must be adhered to.